Navigation Links
KGI Professor Cregg to Be Featured Speaker at Pichia 2012 Conference
Date:10/25/2011

CLAREMONT, Calif., Oct. 25, 2011 /PRNewswire/ -- Keck Graduate Institute (KGI) Research Professor James M. Cregg, PhD, will be the keynote speaker at the upcoming Pichia 2012 conference from February 23 – March 3 in Alpbach, Austria.

Cregg has spent years conducting internationally-renowned research on the development and use of the yeast species, Pichia pastoris, as a system for the production of recombinant proteins.

At the Pichia 2012 Conference he will discuss how the Pichia system began, how it works, and resources available to scientists and drug developers. The event is expected to attract a large audience of global participants from universities, research institutes and companies who wish to exchange ideas on Pichia.

Cregg's work has had a significant impact on the development of pharmaceutical proteins such as chimeric monoclonal antibodies, which work against rheumatoid arthritis, certain cancers and other diseases, as well as human serum albumen, a component of artificial blood plasma.

Many laboratories around the world now use Pichia to make proteins for medical and research applications. Expectations are that within the next decade this yeast expression system will lead to the development of more drugs to combat diseases, according to Cregg.

Cregg has provided keynote addresses at numerous meetings. He serves as a reviewer or editor on five peer-reviewed journals in the biotechnology field: Protein Expression and Purification (executive editor); Applied and Environmental Microbiology; Biotechnology Letters; FEMS Yeast Research; and Molecular Biotechnology.

For more information on the Pichia 2012 conference, visit www.pichia2012.com.

KGI BACKGROUND

Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education through its Master of Bioscience (MBS), Postdoctoral Professional Masters in Bioscience Management (PPM), Postbaccalaureate Premedical Certificate (PPC), PhD and other academic programs. Using team-based learning and real-world projects, KGI's innovative curriculum seamlessly combines applied life sciences, bioengineering, bioethics and business management. KGI also has a robust research program concentrating on the translation of basic discoveries in the life sciences into applications that can benefit society. KGI is a member of The Claremont Colleges, located in Claremont, California.


'/>"/>
SOURCE Keck Graduate Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
2. Nature offers key lessons on harvesting solar power, says U of T chemistry professor
3. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
4. INRS professor Federico Rosei awarded Rutherford Memorial Medal for Chemistry
5. UT professors pathogen research inspires robotics design for medicine and military
6. UCSB professor receives Presidential Green Chemistry Challenge Award
7. Enhanced electrical energy storage may result from professors research
8. NJIT professor develops a biologically inspired catalyst, an active yet inert material
9. Engineering professor wins award for pioneering work expected to improve electronic devices
10. Grove School professor leads new metamaterials center
11. Queens University professor uses nanotechnology to prolong machine and engine life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):